Active	Status	Sponsor type	Region	Phase	Filter
3 Active 2 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GX-19N / Genexine, Binex, GenNBio, PT Kalbe Farma
NCT04715997: Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults	Active, not recruiting	1/2	170	RoW	GX-19N, Dose A, Placebo, Normal saline	Genexine, Inc.	SARS-CoV-2	07/21	06/22
NCT04445389: Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults	Active, not recruiting	1/2	60	RoW	GX-19, DNA vaccine expressing SARS-CoV-2 S-protein antigen, Saline	Genexine, Inc.	SARS-CoV-2	12/21	03/22
NCT04915989: Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals	Completed	1	30	RoW	GX-19N, Dose A	Genexine, Inc.	SARS-CoV-2	04/22	04/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
GX-19N / Genexine, Binex, GenNBio, PT Kalbe Farma
NCT04715997: Safety and Immunogenicity Study of GX-19N, a COVID-19 Preventive DNA Vaccine in Healthy Adults	Active, not recruiting	1/2	170	RoW	GX-19N, Dose A, Placebo, Normal saline	Genexine, Inc.	SARS-CoV-2	07/21	06/22
NCT04445389: Safety and Immunogenicity Study of GX-19, a COVID-19 Preventive DNA Vaccine in Healthy Adults	Active, not recruiting	1/2	60	RoW	GX-19, DNA vaccine expressing SARS-CoV-2 S-protein antigen, Saline	Genexine, Inc.	SARS-CoV-2	12/21	03/22
NCT04915989: Safety and Immunogenicity of GX-19N, a COVID-19 Preventive DNA Vaccine in Elderly Individuals	Completed	1	30	RoW	GX-19N, Dose A	Genexine, Inc.	SARS-CoV-2	04/22	04/22